United Kingdom Pharmaceuticals

Autolus Therapeutics PLC (AUTL)

Track

The most recent insider activity for Autolus Therapeutics PLC occurred on September 16, 2024, involving a proposed sale of 698,741 shares by officer Martin Pule, valued at approximately 2.96 million dollars. There have been no recorded insider transactions within the last three months.
Ticker: AUTL Exchange: NSM
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
No insider activity signals detected

Insider trades have not triggered unusual activity signals for this company.

Top insiders
Trades
Proposed sale 16 Sep 2024
Value US$3,374,146.20 | Price 21.69 | Shares 97,704
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2024-09-16 2024-09-16 PrS Proposed sale
2.9
Martin Pule

Officer

Officer
97,704
21.69
US$3,374,146 		97,704 21.69 US$3,374,146
Explore more

More insider trading research around Autolus Therapeutics PLC

More insider trades in United Kingdom
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Pharmaceuticals companies with insider activity
Insider trading in Europe